Nextstage Clinical Research LLC

1. Currax Pharmaceuticals LLC $925,106 291 payments
2. Davol Inc. $598,191 7 payments
3. Genentech, Inc. $268,321 67 payments
4. Pfizer Inc. $118,854 17 payments
5. Linvatec Corporation $90,774 7 payments
6. Sumitomo Pharma America, Inc. $89,364 11 payments
7. Heron Therapeutics, Inc. $50,465 13 payments
8. ITI, Inc. $45,225 18 payments
9. Janssen Research & Development, LLC $36,836 7 payments
10. Providence Medical Technology, Inc. $30,448 8 payments

1. Hem001 $598,191 7 payments
2. NB (Contrave) Cardiovascular Outcomes Trial $567,598 161 payments
3. NB (Contrave) Cardiovascular Outcomes Trial $357,508 130 payments
4. Assessing Disease Activity in Minority Patients With Relapsing Multiple Sclerosis Using Ocrelizumab $268,321 67 payments
5. BioBrace Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears $90,774 7 payments
6. A Multi-Center, Prospective, Observational Study of Patients Being Treated With Orgovyx $89,364 11 payments
7. A Phase 3 Randomized Openlabel Study of Pf06821497 Mevrometostat in Combination With Enzalutamide Compared With Enzalutamide Or Docetaxel in Participants With Metastatic Castration Resistant Prostate Cancer Previously Treated With Abiraterone Acetate Mevpro1 $61,690 7 payments
8. A Phase 2, Two-Part, Multicenter Study of Htx-011 in Spinal Surgery $46,145 10 payments
9. A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Risk Non-Muscle Invasive Bladder Canc $36,836 7 payments
10. Fuse Study $30,448 8 payments

1. Other $90,774 7 payments
2. Overhead $12,000 1 payment
3. Patient care $9,220 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.